These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23882730)

  • 21. Efficacy of an unsupervised ambulatory treatment regimen for smear-negative pulmonary tuberculosis and tuberculous pleural effusion in Malawi.
    Harries AD; Nyangulu DS; Banda H; Kang'ombe C; Van der Paal L; Glynn JR; Subramanyam VR; Wirima JJ; Salaniponi FM; Maher D; Nunn P
    Int J Tuberc Lung Dis; 1999 May; 3(5):402-8. PubMed ID: 10331729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen.
    Gopi PG; Chandrasekaran V; Subramani R; Santha T; Thomas A; Selvakumar N; Narayanan PR
    Indian J Med Res; 2006 Jun; 123(6):807-14. PubMed ID: 16885603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia.
    Kherosheva T; Thorpe LE; Kiryanova E; Rybka L; Gerasichev V; Shulgina M; Nemtsova E; Aptekar T; Kluge H; Jakubowiak W; Grzemska M; Aquino G; Wells C; Kazionny B
    Int J Tuberc Lung Dis; 2003 Nov; 7(11):1045-51. PubMed ID: 14598963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tuberculosis annual report 2009--series 9. Treatment of TB (2)].
    ; ;
    Kekkaku; 2012 Apr; 87(4):351-5. PubMed ID: 22708130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
    Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment outcomes in culture positive pulmonary tuberculosis].
    Siemion-Szcześniak I; Kuś J
    Pneumonol Alergol Pol; 2009; 77(1):11-22. PubMed ID: 19308905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia.
    Lienhardt C; Manneh K; Bouchier V; Lahai G; Milligan PJ; McAdam KP
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):712-8. PubMed ID: 9755924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morbidity and mortality at five years after initiating Category I treatment among patients with new sputum smear positive pulmonary tuberculosis.
    Lisha PV; James PT; Ravindran C
    Indian J Tuberc; 2012 Apr; 59(2):83-91. PubMed ID: 22838205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Tuberculosis Annual Report 2008--Series 9. Treatment of TB (2)].
    Tuberculosis Surveillance Center, RIT, JATA
    Kekkaku; 2010 Jul; 85(7):643-6. PubMed ID: 20715550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment.
    Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High success rate of TB treatment among Bhutanese refugees in Nepal.
    Bam TS; Enarson DA; Hinderaker SG; Chapman RS
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):54-8. PubMed ID: 17217130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
    Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
    PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High early death rate in tuberculosis patients in Malawi.
    Harries AD; Hargreaves NJ; Gausi F; Kwanjana JH; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Nov; 5(11):1000-5. PubMed ID: 11716335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PULMONARY TUBERCULOSIS TREATMENT OUTCOME AMONG FOREIGN NATIONALS RESIDING IN OSAKA CITY].
    Tsuda Y; Matsumoto K; Komukai J; Kasai S; Warabino Y; Hirota S; Koda S; Shimouchi A
    Kekkaku; 2015 Mar; 90(3):387-93. PubMed ID: 26477107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing outcomes in new pulmonary sputum positive and sputum negative cases under RNTCP in rural India.
    Mukherjee A; Singla R; Saha I
    Indian J Tuberc; 2009 Jul; 56(3):144-50. PubMed ID: 20349756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan.
    Yen YF; Yen MY; Shih HC; Deng CY
    Trans R Soc Trop Med Hyg; 2012 May; 106(5):303-8. PubMed ID: 22387265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
    Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
    J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K; Altraja A
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Estimation of the future epidemiological situation of tuberculosis in Japan].
    Ohmori M; Yoshiyama T; Ishikawa N
    Kekkaku; 2008 Apr; 83(4):365-77. PubMed ID: 18516900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When are follow-up sputum smears actually examined in patients treated for new smear-positive pulmonary tuberculosis?
    Harries AD; Gausi F; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):440-4. PubMed ID: 15141736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.